Safelock is now sRCA, again

The Safelock technology was initially developed under the working title sRCA, or superRCA as in Super Rolling Circle Amplification; super referring to the extra second step of rolling, achieving the outstanding superiority.

The technology was then renamed to Safelock. When we realized just how natural the sRCA had become, and that it had stuck with other researchers, we decided to go back to the roots and formally name the technology sRCA as in superRCA.

superRCA technology is the result of 10+ years of research at The Department of  Immunology, Genetics and Pathology at Uppsala University. Our method is based on rolling circle amplification and padlock probe technique, combined into a single tube assay for super sensitive nucleic acid sequence detection. You can read more about the technology here.

Share this article

Recommended articles

Rarity Bioscience at the CYTO 2024 Conference

Rarity Bioscience’s Linus Bosaeus and Lei Chen was at the CYTO 2024 Conference in Edinburgh, to present the study Ultra-sensitive Molecular MRD on Flow Cytometer using superRCA Mutation Assay, showcasing our new ultra-sensitive mutation detection technology superRCA.

Read more »

Rarity Bioscience at the Nordic Precision Medicine Forum

Rarity Bioscience was at the Nordic Precision Medicine Forum, presenting an engaging study that highlights the latest advancements in precision oncology: ”Ultra-sensitive Monitoring of Minimal Residual Disease (MRD) for Cancer Patients, using superRCA Mutation Assays with Flow Cytometry Readout”

Read more »